<?xml version="1.0" encoding="UTF-8"?>
<p>A virus-like replicon particle (VRP) vaccine candidate based on IbAr 10200 strain but with the GPC sequence from the Oman-1998 strain provided complete protection against lethal challenge following a single high dose (10
 <sup>5</sup> TCID
 <sub>50</sub> of VRP) subcutaneous vaccination in IFNAR
 <sup>−/−</sup> mouse model.
 <sup>
  <xref rid="B109" ref-type="bibr">109</xref>
 </sup> In contrast, a low dose (10
 <sup>3</sup> TCID
 <sub>50</sub> of VRP) vaccination protected seven out of nine mice (
 <xref rid="tb1" ref-type="table">Table 1</xref>). In a related study, the VRP candidate vaccine provided complete protection against challenge with each of the CCHFV IbAr 10200 strain, the CCHFV-Turkey strain, and the CCHFV-Oman-97 strain
 <sup>
  <xref rid="B110" ref-type="bibr">110</xref>
 </sup> (
 <xref rid="tb1" ref-type="table">Table 1</xref>).
</p>
